| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/28/2001 | WO2001045599A1 Tissue sensitizing compounds for females with methods and apparatus for the delivery of these compounds |
| 06/28/2001 | WO2001045577A2 Intervertebral disc treatment devices and methods |
| 06/28/2001 | WO2001045552A1 Ingestible device for the release of substances at district locations in alimentary canal |
| 06/28/2001 | WO2001045519A1 Enhanced ingestible products |
| 06/28/2001 | WO2000078357A3 Hyaluronic acid film and matrix for sustained gene transfer |
| 06/28/2001 | WO2000078322A3 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 06/28/2001 | WO2000074661A3 Solubility enhancement of drugs in transdermal drug delivery systems and methods of use |
| 06/28/2001 | WO2000074660A3 Substrate sections with improved storage stability during their storage in bags, and a method for producing the same |
| 06/28/2001 | WO2000072855A3 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 06/28/2001 | WO2000071154A3 Stability, biocompatibility optimized adjuvant (sba) for enhancing humoral and cellular immune response |
| 06/28/2001 | WO2000067773A3 Combinations of immunosupressive agents for the treatment or prevention of graft rejections |
| 06/28/2001 | WO2000066116A3 Stable solid pharmaceutical compositions containing enalapril maleate |
| 06/28/2001 | WO2000042987A8 Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections |
| 06/28/2001 | WO2000027437A9 Polymer grafting by polysaccharide synthases |
| 06/28/2001 | WO1999000112A8 Sucralfate-containing composition and process for the preparation thereof |
| 06/28/2001 | WO1998009597A3 Cushioning beads and tablet comprising the same capable of forming a suspension |
| 06/28/2001 | US20010005728 By administering a controlled release of oxybutynin in given dosage |
| 06/28/2001 | US20010005726 Includes an organic solvent, a surfactant, and an oil; high in vivo bioavailability |
| 06/28/2001 | US20010005720 Method of treating chronic progressive vascular scarring diseases |
| 06/28/2001 | US20010005716 Core of an acid labile medicant such as didanosine, a binder and a disintegrant, and a coating of a methacrylic acid copolymer and plasticizer which protects drug at low pH but releases drug at pH of 4.5 or higher, anti-adherent |
| 06/28/2001 | US20010005514 L-ascorbic acid and pectin composition |
| 06/28/2001 | US20010005513 With water insoluble starch carrier; allows dry storage and lower doses of active ingredient |
| 06/28/2001 | US20010005512 Controlled release formulation of divalproex sodium |
| 06/28/2001 | US20010005501 A pharmaceutical composition comprising a mixture of hyaluronic acid and liposomes, and is free of superoxide dismutase; improves stability of liposomes; gene therapy; cyclosporin A delivery |
| 06/28/2001 | DE19962926A1 Comminution of a substance, especially a cardiovascular drug, comprises mixing the substance with lactose and comminuting the mixture in a jet mill |
| 06/28/2001 | DE19962300A1 New N-benzylindolyl glyoxylic acid derivatives are useful as antitumor agents |
| 06/28/2001 | DE19961897A1 Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen Using a film coating as taste coating of pharmaceutical dosage forms |
| 06/28/2001 | DE19961733A1 Oil-in-water emulsion comprising cyclosporin, is useful for treating neurological disease and as a neuroprotectant, comprises triglyceride, natural emulsifier and a hypertonicity agent |
| 06/28/2001 | DE19959913A1 Acetylsalicylsäure enthaltendes transdermales System zur Behandlung von Migräne Aspirin-containing transdermal system for the treatment of migraine |
| 06/28/2001 | DE19957234A1 Pharmazeutisches Pflaster enthaltend ätherische Öle Pharmaceutical plaster containing essential oils |
| 06/28/2001 | DE19946192A1 Topical composition useful for expectoration, aiding digestion and treating hemorrhoids contains analgesics |
| 06/28/2001 | CA2717246A1 Use of quinoline and quinolizinone derivatives as chemotherapeutic agents |
| 06/28/2001 | CA2395200A1 Use of biologically active vitamin d compounds for the prevention and treatment of inflammatory bowel disease |
| 06/28/2001 | CA2395108A1 Method of treating gastrointestinal tract disease with purinergic receptor agonists |
| 06/28/2001 | CA2394901A1 Chitosan biopolymer for the topical delivery of active agents |
| 06/28/2001 | CA2394822A1 Mixed structures resulting from the incorporation of a biological macromolecule, particularly dna, into a liquid-crystal phase of amphiphiles, and vesicles obtained from these structures |
| 06/28/2001 | CA2394568A1 Tissue sensitizing compounds for females with methods and apparatus for the delivery of these compounds |
| 06/28/2001 | CA2394520A1 Sensitive substance encapsulation |
| 06/28/2001 | CA2394222A1 Sustained-release formulation of a cyclooxygenase-2 inhibitor |
| 06/28/2001 | CA2393018A1 A stable immunogenic composition for frozen storage |
| 06/27/2001 | EP1111390A1 Method for evaluating lipid a analog-containing injections |
| 06/27/2001 | EP1111050A2 Human procalcitonin, its production and use |
| 06/27/2001 | EP1110554A1 Medicinal compositions for treating eye diseases |
| 06/27/2001 | EP1110553A1 Sustained release oral preparations of fasudil hydrochloride |
| 06/27/2001 | EP1110550A2 Composition comprising ascorbic acid and pectin |
| 06/27/2001 | EP1110547A2 Helium and neon as means delivering drug in inhaler |
| 06/27/2001 | EP1110546A1 Method of preparing a water soluble film |
| 06/27/2001 | EP1110545A2 Pharmaceutical preparations for the targeted treatment of Morbus Crohn and Colitis Ulcerosa |
| 06/27/2001 | EP1110544A2 Use of a film coating as taste masking coating for oral dosage forms |
| 06/27/2001 | EP1110543A2 Extended release oral dosage composition |
| 06/27/2001 | EP1110542A2 Once-a-day metoprolol oral dosage form |
| 06/27/2001 | EP1110541A1 Controlled release composition comprising a sustained release layer and a fast release layer |
| 06/27/2001 | EP1110540A1 Melt granulated sucralfate preparations |
| 06/27/2001 | EP1110462A2 Encapsulated multifunctional, biologically active food ingredient, process for its manufacture and use thereof |
| 06/27/2001 | EP1109926A1 Condensed plasmid-liposome complex for transfection |
| 06/27/2001 | EP1109837A1 Method for producing ultra-pure alginates |
| 06/27/2001 | EP1109586A2 External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
| 06/27/2001 | EP1109583A1 Method and device for delivery of therapeutic agents in conjuction with isotope seed placement |
| 06/27/2001 | EP1109581A1 Preserved cyclodextrin-containing compositions |
| 06/27/2001 | EP1109563A2 End modified thermal responsive hydrogels |
| 06/27/2001 | EP1109558A2 Sustained release ranolazine formulations |
| 06/27/2001 | EP1109551A1 4-amino-3-mercapto-1,2,4-triazoles |
| 06/27/2001 | EP1109541A1 Active ingredient support in the form of a film |
| 06/27/2001 | EP1109540A1 Extended release acetaminophen |
| 06/27/2001 | EP1109539A1 Nanogel networks and biological agent composition thereof |
| 06/27/2001 | EP1109538A1 Anti-inflammatory pharmaceutical formulations |
| 06/27/2001 | EP1109537A1 Immediate release tablet |
| 06/27/2001 | EP1109536A1 New solid dose form of nanoparticulate naproxen |
| 06/27/2001 | EP1109535A1 Extended release acetaminophen |
| 06/27/2001 | EP1109534A1 Quick release pharmaceutical compositions of drug substances |
| 06/27/2001 | EP1109533A1 Pulmonary delivery of liposome-encapsulated cannabinoids |
| 06/27/2001 | EP1109532A1 Oral micro-emulsion composition of silybin |
| 06/27/2001 | EP1109531A1 Local delivery of medications to the heart |
| 06/27/2001 | EP1109526A1 Improved stability for injection solutions |
| 06/27/2001 | EP0909158A4 Aqueous product comprising oil microdroplets stabilized by in-situ polymerized vinyl monomer and a thickening agent |
| 06/27/2001 | EP0767669B1 New pharmaceutical preparation for pain management |
| 06/27/2001 | EP0743854B1 Anti-tumour medical preparation on the basis of carboplatin and the method of its production |
| 06/27/2001 | EP0727979B1 Novel composition |
| 06/27/2001 | EP0676962B1 Enhanced pharmaceutical compositions for skin penetration for piroxicam |
| 06/27/2001 | CN2436153Y Stick chip for penicillin anaphylaxis skin test |
| 06/27/2001 | CN1301182A Solid preparations for oral administration of drugs relating to genes |
| 06/27/2001 | CN1301179A Hemoglobin-polysaccharide conjugates |
| 06/27/2001 | CN1301178A Solution comprising prostaglandins and benzyl alcohol |
| 06/27/2001 | CN1301177A Anti-inflammatory eye drops |
| 06/27/2001 | CN1301176A Use of active P40 conjugates for nasal delivery |
| 06/27/2001 | CN1301172A Sustained-release physiologically active polypeptide and production thereof |
| 06/27/2001 | CN1301171A Cyclosporin preparations |
| 06/27/2001 | CN1301165A Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 06/27/2001 | CN1301163A Controlled release peroral compositions of levosimendan |
| 06/27/2001 | CN1301157A Sustained release preparations |
| 06/27/2001 | CN1301156A Treatment of T-Helper cell tyre 2 mediated immune diseases with retinoid antagonists |
| 06/27/2001 | CN1301155A Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivative process for preparing the same |
| 06/27/2001 | CN1301152A Transdermal therapeutic system containing pergolide |
| 06/27/2001 | CN1301151A Regulated release preparations |
| 06/27/2001 | CN1301150A Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
| 06/27/2001 | CN1301149A Delavirdine tablet formulation |
| 06/27/2001 | CN1301148A Pharmaceutical preparation containing levothyroxine sodium |
| 06/27/2001 | CN1301147A Pharmaceutical compositions capable of being gelled |
| 06/27/2001 | CN1301146A Topical hormonal composition with systemic effect |
| 06/27/2001 | CN1300607A Exterior-applied medicine for quickly treating arthropathy |